{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:00:41Z","timestamp":1785787241818,"version":"3.56.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1097\/01.coc.0000045853.73233.42","type":"journal-article","created":{"date-parts":[[2004,1,30]],"date-time":"2004-01-30T04:04:36Z","timestamp":1075435476000},"page":"73-80","source":"Crossref","is-referenced-by-count":22,"title":["Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease"],"prefix":"10.1097","volume":"27","author":[{"given":"Gregory M.","family":"Chronowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Wilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward N.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul S.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick B.","family":"Hagemeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Barista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Sarris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210128","first-page":"198","article-title":"Radiotherapy in Hodgkin\u2019s disease (malignant granulomatosis): anatomic and clinical foundations; governing principles; results","volume":"41","author":"Gilbert","year":"1939","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"R2-13-20210128","first-page":"299","article-title":"A study in survivals in Hodgkin\u2019s disease treated radiologically","volume":"63","author":"Peters","year":"1950","journal-title":"Am J Roentgenol"},{"key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/bmj.1.5347.1704","article-title":"The cure of Hodgkin\u2019s disease","volume":"1","author":"Easson","year":"1963","journal-title":"BMJ"},{"key":"R4-13-20210128","first-page":"325","article-title":"The Janeway lecture. Hodgkin\u2019s disease\u2014finding the balance between cure and late effects","volume":"5","author":"Donaldson","year":"1999","journal-title":"Cancer J Sci Am"},{"key":"R5-13-20210128","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM197211302872204","article-title":"Nonlymphomatous malignant tumors complicating Hodgkin\u2019s disease. Possible association with intensive therapy","volume":"287","author":"Arseneau","year":"1972","journal-title":"N Engl J Med"},{"key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1200\/JCO.1986.4.6.821","article-title":"Secondary malignancy after treatment of Hodgkin\u2019s disease: an evolving picture","volume":"4","author":"Coleman","year":"1986","journal-title":"J Clin Oncol"},{"key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/1097-0142(19880615)61:12<2541::AID-CNCR2820611225>3.0.CO;2-G","article-title":"Solid cancer risk after treatment of Hodgkin\u2019s disease","volume":"61","author":"Boivin","year":"1988","journal-title":"Cancer"},{"key":"R8-13-20210128","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin\u2019s disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/annonc\/8.suppl_1.S115","article-title":"Hodgkin\u2019s disease: complications of therapy and excess mortality","volume":"8","author":"Hoppe","year":"1997","journal-title":"Ann Oncol"},{"key":"R10-13-20210128","first-page":"13a","article-title":"Superiority of EBVP chemotherapy in combination with involved field irradiation (EBVD\/IF) over subtotal nodal irradiation (STNI) in favorable clinical stage (CS) I-II Hodgkin\u2019s disease: the EORTC-GPMC H7F randomized trial [Abstract 44]","volume":"16","author":"Carde","year":"1997","journal-title":"J Clin Oncol"},{"key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/annonc\/9.suppl_5.S57","article-title":"The role of radiotherapy for early stage Hodgkin\u2019s disease: limitations and perspectives","volume":"9","author":"Cosset","year":"1998","journal-title":"Ann Oncol"},{"key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1200\/JCO.1998.16.3.830","article-title":"Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin\u2019s disease: a meta-analysis of 23 randomized trials involving 3,888 patients. International Hodgkin\u2019s Disease Collaborative Group","volume":"16","author":"Specht","year":"1998","journal-title":"J Clin Oncol"},{"key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0167-8140(01)80301-7","article-title":"Combined modality, chemo- and radiation, in favourable stage I and II Hodgkin\u2019s disease is superior to radiotherapy alone [Abstract 159]","volume":"58","author":"Meerwaldt","year":"2001","journal-title":"Radiother Oncol"},{"key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1097-0142(19900701)66:1<80::AID-CNCR2820660116>3.0.CO;2-9","article-title":"Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas","volume":"66","author":"Lavey","year":"1990","journal-title":"Cancer"},{"key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.304.6835.1137","article-title":"Risk of second primary cancers after Hodgkin\u2019s disease by type of treatment: analysis of 2486 patients in the British National Lymphoma Investigation","volume":"304","author":"Swerdlow","year":"1992","journal-title":"BMJ"},{"key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.2910520502","article-title":"Lung cancer following Hodgkin\u2019s disease: a case control study","volume":"52","author":"Kaldor","year":"1992","journal-title":"Int J Cancer"},{"key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.annonc.a058414","article-title":"Hodgkin\u2019s disease: study of treatment intensities and incidences of second malignancies","volume":"4","author":"Rodriguez","year":"1993","journal-title":"Ann Oncol"},{"key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1200\/JCO.1994.12.2.312","article-title":"Second cancer risk following Hodgkin\u2019s disease: a 20-year follow-up study","volume":"12","author":"van Leeuwen","year":"1994","journal-title":"J Clin Oncol"},{"key":"R19-13-20210128","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1182\/blood.V87.9.3625.bloodjournal8793625","article-title":"Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin\u2019s disease: long-term analysis of risk factors and outcome","volume":"87","author":"Mauch","year":"1996","journal-title":"Blood"},{"key":"R20-13-20210128","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s002770050556","article-title":"Second malignancies after Hodgkin\u2019s disease: the Munich experience","volume":"78","author":"Munker","year":"1999","journal-title":"Ann Hematol"},{"key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin\u2019s disease in a collaborative British cohort: the relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"key":"R22-13-20210128","first-page":"1860","article-title":"Report of the Committee on Hodgkin\u2019s Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"R23-13-20210128","first-page":"1311","article-title":"Report of the Nomenclature Committee. Rye Classification","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"R24-13-20210128","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin\u2019s disease","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/1097-0142(19900301)65:5<1090::AID-CNCR2820650509>3.0.CO;2-#","article-title":"Role of the gallium scan in Hodgkin\u2019s disease","volume":"65","author":"Hagemeister","year":"1990","journal-title":"Cancer"},{"key":"R26-13-20210128","first-page":"36","article-title":"Treatment of early stages of Hodgkin\u2019s disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy","volume":"31","author":"Hagemeister","year":"1994","journal-title":"Semin Hematol"},{"key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10428199909083389","article-title":"Treatment of stage I and II Hodgkin\u2019s disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy","volume":"34","author":"Tormo","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0360-3016(88)90090-9","article-title":"The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin\u2019s disease: preliminary results","volume":"14","author":"Fuller","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/3.suppl_4.S117","article-title":"Second cancer after the treatment for Hodgkin\u2019s disease: a report from the International Database on Hodgkin\u2019s Disease","volume":"3","author":"Henry-Amar","year":"1992","journal-title":"Ann Oncol"},{"key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJM199603213341201","article-title":"Breast cancer and other second neoplasms after childhood Hodgkin\u2019s disease","volume":"334","author":"Bhatia","year":"1996","journal-title":"N Engl J Med"},{"key":"R32-13-20210128","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0360-3016(00)01513-3","article-title":"The risk of second malignant tumors and its consequences for the overall survival of Hodgkin\u2019s disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital","volume":"49","author":"Cellai","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin\u2019s disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/bjc.1997.19","article-title":"Second malignancy in patients with Hodgkin\u2019s disease treated at the Royal Marsden Hospital","volume":"75","author":"Swerdlow","year":"1997","journal-title":"Br J Cancer"},{"key":"R36-13-20210128","first-page":"1032","article-title":"Treatment of early-stage Hodgkin\u2019s disease with four cycles of ABVD followed by adjuvant radiotherapy: analysis of efficacy and long-term toxicity","volume":"85","author":"Brusamolino","year":"2000","journal-title":"Haematologica"},{"key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/ctrv.1999.0114","article-title":"Hodgkin\u2019s disease\u2014new treatment strategies toward the cure of patients","volume":"25","author":"Jox","year":"1999","journal-title":"Cancer Treat Rev"},{"key":"R38-13-20210128","first-page":"812","article-title":"The risk of acute leukemia in patients treated for Hodgkin\u2019s disease is significantly higher after combined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study","volume":"83","author":"Brusamolino","year":"1998","journal-title":"Haematologica"},{"key":"R39-13-20210128","first-page":"283a","article-title":"High rate of second primary neoplasms (SPN) among Hodgkin\u2019s disease (HD) patients (Pts) treated with ABVD, a dacarbazine (DTIC)-containing chemotherapy (CT). Eight year results of a randomized trial of the Goelams Group [Abstract 1128]","volume":"20","author":"Andrieu","year":"2001","journal-title":"J Clin Oncol"},{"key":"R40-13-20210128","first-page":"768a","article-title":"Involved (IF) radiotherapy is as effective as extended field (EF) radiotherapy after 2 cycles of COPP\/ABVD in patients (pts) with intermediate-stage Hodgkin\u2019s disease (HD): A randomized multicenter study [Abstract 3199]","volume":"98","author":"Engert","year":"2001","journal-title":"Blood"},{"key":"R41-13-20210128","first-page":"281a","article-title":"Ten-years experience with ABVD plus radiotherapy: subtotal nodal (STNI) vs involved field (IFRT) in early-stage Hodgkin\u2019s disease (Hd) [Abstract 1120]","volume":"20","author":"Bonfante","year":"2001","journal-title":"J Clin Oncol"},{"key":"R42-13-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast cancer after treatment of Hodgkin\u2019s disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"R43-13-20210128","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO;2-2","article-title":"High risk of breast carcinoma after irradiation of young women with Hodgkin\u2019s disease","volume":"79","author":"Aisenberg","year":"1997","journal-title":"Cancer"},{"key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(00)00438-7","article-title":"An alternative mantle irradiation technique using 3D CT-based treatment planning for female patients with Hodgkin\u2019s disease","volume":"47","author":"Vuong","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ijc.2910390506","article-title":"Second malignancies following testicular cancer, ovarian cancer and Hodgkin\u2019s disease: an international collaborative study among cancer registries","volume":"39","author":"Kaldor","year":"1987","journal-title":"Int J Cancer"},{"key":"R46-13-20210128","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198801143180203","article-title":"Risk of second cancer after treatment for Hodgkin\u2019s disease","volume":"318","author":"Tucker","year":"1988","journal-title":"N Engl J Med"},{"key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-102-1-37","article-title":"Cutaneous malignant melanoma after Hodgkin\u2019s disease","volume":"102","author":"Tucker","year":"1985","journal-title":"Ann Intern Med"},{"key":"R48-13-20210128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiology.208.3.9722855","article-title":"Stage I Hodgkin\u2019s disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1967\u20131997","volume":"208","author":"Vlachaki","year":"1998","journal-title":"Radiology"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.coc.0000045853.73233.42","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:05:22Z","timestamp":1785783922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200402000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000045853.73233.42","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}